Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001193125-25-314156

Chief Regulatory Officer sold 10,000 shares at $45.31 ($453,053)

  • Chief Regulatory Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Turner William D. · Chief Regulatory Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-08 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $15.53 $155,300 32,500 D
2025-12-08 Sale : show line 2 in the form 10b5-1 −10,000 $45.31 $453,053 22,500 D
Open-market sales · 10,000 sh · avg $45.31 · $453,053

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-08 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −10,000 255,000 D
Loading xslF345X05/ownership.xml…